BioSpace News Archive

Pharm Country

Findings Presented from State of Smoking Survey of More than 17,000 People Worldwide

Media worldwide are invited to attend a press event announcing the results of the 2018 State of Smoking Survey, a study commissioned by the Foundation for a Smoke-Free World that aims to better understand why people smoke, what motivates smokers to want to quit, and what makes quitting difficult.

March 12, 2018
·
1 min read
New Study Investigates the Performance of Masimo SpHb® During Acute Bleeding and After Fluid Resuscitation

Masimo announced the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo noninvasive and continuous hemoglobin (SpHb®).

March 12, 2018
·
2 min read
Drug Development

XW Labs Initiates First-in-Human Phase I Study for Novel Narcolepsy Treatment

XW Laboratories Inc. announced the initiation of a Phase 1 single ascending dose (SAD) study in healthy subjects in Australia for its novel proprietary compound XW10172 to assess safety, tolerability and pharmacokinetics.

March 12, 2018
·
1 min read
Business

Chi-Med Reports Final Results for the Year Ended December 31, 2017 and Updates Shareholders on Key Clinical Programs

Chi-Med Reports Final Results for the Year Ended December 31, 2017 and Updates Shareholders on Key Clinical Programs

March 12, 2018
·
26 min read
Drug Development

NGM Bio Announces Publication In The Lancet Of Phase 2 Study Of NGM282 In NASH Patients And Upcoming Presentations Of NGM282 NASH Histology Data And NGM282 PSC Data At The International Liver Congress 2018

Statistically significant and clinically meaningful improvements observed in MRI measures of liver fat and serum biomarkers of liver function, lipid metabolism and fibrosis

March 12, 2018
·
5 min read
Business

ALASTIN Skincare, Inc. Announces Appointment of Ann Rhoads and Elisabeth Sandoval to Company’s Board of Directors

Alastin Skincare, Inc. is a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products with proprietary TriHex Technology® that enhance, protect, and maintain healthy skin for a lifetime

March 12, 2018
·
2 min read
Biotech Bay

ITUS will Present Data at the American Association of Cancer Research (AACR) Annual Meeting

Data from its ongoing study utilizing Cchek™, ITUS’s artificial intelligence (AI) driven early cancer detection technology.

March 12, 2018
·
4 min read
Smartphone-based Retinal Imaging Together With Artificial Intelligence Powers Automated, Sensitive and Early Detection of Retinopathy

90% of the vision loss due to DR is preventable by early detection and timely treatment.

March 12, 2018
·
2 min read
Drug Development

Alnylam Retains Global Rights to Lumasiran, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1 (PH1)

Company plans to accelerate development with Phase 3 start in late 2018.

March 12, 2018
·
9 min read
Business

TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding

Company becomes first to license TAE Technologies’ accelerator-based beam technology for clinical investigation.

March 12, 2018
·
4 min read